+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Local Anesthesia Drugs Market - Global Forecast 2026-2032- Product Image
Local Anesthesia Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Local Anesthesia Drugs Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715948
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Local Anesthesia Drugs Market is projected to reach USD 3.71 Billion in 2026. It is expected to continue growing at a CAGR of 5.74%, reaching USD 5.20 Billion by 2032.

Local anesthesia drugs are indispensable across dental care, ambulatory surgery, obstetrics, dermatology, ophthalmology, emergency medicine, and pain management, where targeted nerve blockade enables procedures while limiting systemic sedation requirements. The category includes injectable and topical local anesthetics such as lidocaine, bupivacaine, ropivacaine, mepivacaine, prilocaine, articaine, chloroprocaine, and tetracaine, alongside vasoconstrictor-containing formulations that extend duration and reduce bleeding in appropriate settings. Clinical demand is supported by procedure migration toward outpatient and office-based care, rising dental and aesthetic interventions, increasing use of regional anesthesia in enhanced recovery after surgery protocols, and continued need for safe perioperative analgesia. At the same time, stakeholders are navigating stricter safety expectations around local anesthetic systemic toxicity, preservative and excipient selection, medication labeling, sterile manufacturing reliability, and cold-chain or controlled storage where applicable. The strategic focus is shifting from simple drug availability toward differentiated duration of action, predictable onset, improved safety margins, procedural workflow efficiency, and evidence-based dosing across patient groups, including pediatrics, geriatrics, pregnant patients, and individuals with hepatic, cardiac, or renal comorbidities.

Transformative Shifts Reshaping Local Anesthesia Drugs

The local anesthesia drugs landscape is being reshaped by the expansion of minimally invasive procedures, the growth of ambulatory surgery centers, and the wider adoption of regional anesthesia as part of opioid-sparing pain strategies. Healthcare systems are prioritizing faster discharge, reduced postoperative opioid exposure, and procedure-specific analgesia, which is increasing attention on longer-acting agents, peripheral nerve blocks, neuraxial techniques, and topical anesthetic formats for dermatologic and mucosal applications. Regulatory and quality expectations are also transforming supplier priorities, with greater emphasis on sterile injectable capacity, impurity controls, container-closure integrity, pharmacovigilance, and clear dosing guidance. In dentistry, articaine and lidocaine remain prominent because of rapid onset and broad procedural utility, while bupivacaine and ropivacaine are frequently positioned for longer-duration analgesia in surgical and obstetric settings. Another important shift is the increasing clinical scrutiny of additive technologies, liposomal or depot approaches, and preservative-free formulations, particularly where extended analgesia, reduced rescue medication use, or compatibility with neuraxial use is clinically relevant. These changes are pushing manufacturers, distributors, and providers to align product portfolios with evidence, supply resilience, and setting-specific administration needs.

Cumulative Impact of Artificial Intelligence on Local Anesthesia Drugs

Artificial intelligence is increasingly influencing the local anesthesia drugs ecosystem across discovery, development, manufacturing, clinical decision support, and supply chain operations. In early-stage research, AI-enabled modeling can support structure-activity analysis, toxicity prediction, formulation screening, and excipient compatibility assessments, helping teams prioritize candidates and delivery systems with desirable onset, duration, and safety characteristics. In clinical operations, machine learning tools can assist with risk stratification for adverse events, dose optimization support, documentation quality, and ultrasound-guided regional anesthesia workflow analysis, provided they remain clinically validated and supervised by qualified professionals. In pharmacovigilance, natural language processing can accelerate signal detection from adverse event reports, literature, and real-world data, improving surveillance for local anesthetic systemic toxicity, allergic-type reactions, medication errors, or off-label use patterns. AI is also strengthening manufacturing and distribution through predictive maintenance, visual inspection support, contamination-risk analytics, demand sensing, and inventory optimization for sterile injectables. The cumulative impact is not a replacement for clinician judgment or regulatory evidence, but an increasingly data-driven operating model that can enhance safety, improve supply continuity, and accelerate formulation and process decisions in local anesthesia drugs.

Key Regional Insights for Local Anesthesia Drugs

In Asia-Pacific, local anesthesia drugs demand is supported by high procedural volumes, expanding dental care access, growing medical tourism in selected countries, and increasing investments in hospital and ambulatory infrastructure, with China, India, Japan, South Korea, and Australia representing distinct clinical and regulatory environments. Europe is characterized by mature anesthesia practice standards, strong emphasis on pharmacovigilance, and broad adoption of regional anesthesia in hospital systems, while European healthcare policies continue to promote cost-effective outpatient care and safe perioperative pain management. North America shows advanced utilization of ambulatory surgery, dental procedures, ultrasound-guided nerve blocks, and opioid-sparing protocols, with stringent sterile injectable quality expectations and strong attention to medication safety. Latin America is experiencing increasing use of local anesthetics in dentistry, obstetrics, emergency care, and surgical procedures, although procurement consistency and access to specialized formulations vary by country and public-private care setting. Across Africa, local anesthesia drugs remain essential for surgical access, maternal health, dental procedures, and emergency interventions, with public health priorities focused on affordability, availability, cold-chain reliability where needed, and training in safe administration. The Middle East is strengthening demand through hospital modernization, private healthcare expansion, and growth in elective and specialty procedures, particularly in GCC countries, where regulatory alignment and advanced clinical infrastructure are supporting wider use of modern anesthetic protocols.

Key Group Insights for Local Anesthesia Drugs

Across NATO countries, local anesthesia drugs are tied to advanced surgical readiness, trauma care, dental services, and hospital-based emergency preparedness, making supply assurance and sterile injectable resilience important strategic considerations. G7 economies generally demonstrate mature anesthesia guidelines, strong regulatory oversight, high procedural intensity, and advanced adoption of regional anesthesia and outpatient surgery, with consistent emphasis on medication safety, quality systems, and evidence-based clinical protocols. BRICS countries reflect a more diverse landscape: China and India are scaling healthcare access and pharmaceutical production capacity, Brazil and South Africa support expanding procedural care needs, and Russia maintains significant hospital-based demand, creating varied opportunities tied to access, local manufacturing, and formulary standardization. Within the European Union, harmonized regulatory frameworks, pharmacovigilance requirements, and cross-border quality expectations support consistent evaluation of local anesthesia drugs, while national reimbursement and procurement systems influence product adoption. ASEAN countries are seeing growing procedural volumes, medical tourism, and dental service expansion, but market conditions differ widely between advanced hospital hubs and access-constrained settings. In the GCC, investment in tertiary hospitals, specialty clinics, and elective care is supporting demand for reliable anesthetic products, with procurement decisions often influenced by international quality certifications, formulary evidence, and supply continuity.

Key Country Insights for Local Anesthesia Drugs

China is strengthening its role through large procedural volumes, expanding hospital networks, and domestic pharmaceutical capabilities, while regulatory reforms continue to elevate quality and clinical evidence expectations. The United States remains a major center for ambulatory surgery, dental anesthesia, regional nerve block adoption, and opioid-sparing perioperative care, with strong oversight of sterile injectables and adverse event monitoring. Japan emphasizes high standards for procedural safety, aging-population care, and hospital quality systems, supporting demand for predictable and well-characterized local anesthetics. India combines rising surgical access, dental service growth, and increasing private healthcare capacity, while affordability and availability remain central to adoption. Germany, France, Italy, and Spain benefit from established hospital systems, regional anesthesia expertise, and European pharmacovigilance frameworks, although procurement practices and hospital formularies vary by national health system. The United Kingdom continues to prioritize day-case surgery, safe analgesia pathways, and evidence-led formulary decisions within a publicly guided care environment. Australia demonstrates advanced use of regional anesthesia, dental care, and outpatient procedures supported by robust clinical governance, while South Korea combines technologically advanced hospitals with strong demand for cosmetic, dental, and surgical procedures. Canada reflects high safety expectations, broad dental and surgical utilization, and geographically influenced distribution requirements. Russia maintains demand across hospital surgery, dentistry, and emergency care, with access shaped by local procurement and regulatory conditions. Brazil and Mexico represent important Latin American procedural hubs where private and public healthcare systems drive demand for widely used anesthetics, and supply reliability remains a critical factor across regions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize resilient sterile manufacturing, robust quality assurance, and diversified sourcing strategies to reduce disruption risks in essential local anesthesia drugs. Portfolio planning should align with clinical use cases by balancing rapid-onset agents, long-acting formulations, preservative-free options, dental cartridges, topical products, and procedure-specific presentations that reduce medication errors and improve workflow. Organizations should invest in pharmacovigilance, clinician education, and clear labeling to support safe dosing, aspiration practices where relevant, recognition of local anesthetic systemic toxicity, and appropriate lipid emulsion preparedness in clinical settings. Evidence generation should focus on clinically meaningful outcomes such as duration of analgesia, rescue analgesic use, discharge readiness, adverse event rates, patient satisfaction, and compatibility with enhanced recovery protocols. Commercial teams should tailor access strategies to regional realities, including tender-driven procurement, private clinic growth, dental distribution networks, and hospital formulary requirements. Leaders should also adopt AI-enabled quality analytics, demand sensing, and adverse event surveillance while ensuring regulatory compliance, data integrity, and human clinical oversight.

Research Methodology for Local Anesthesia Drugs Analysis

This executive summary is built on a structured secondary research approach using publicly available and verifiable sources, including regulatory guidance, pharmacopoeial standards, clinical practice guidelines, anesthesia society recommendations, peer-reviewed medical literature, public health publications, and government healthcare resources. The analysis considers therapeutic applications, formulation categories, clinical safety issues, regional healthcare infrastructure, procurement dynamics, and procedural care trends relevant to local anesthesia drugs. Information was assessed through triangulation across clinical, regulatory, and healthcare delivery perspectives to ensure consistency and practical relevance. The methodology excludes unsupported projections, undisclosed proprietary estimates, company-level comparisons, and speculative financial assumptions. Emphasis is placed on data-backed trends such as outpatient procedure growth, regional anesthesia adoption, opioid-sparing protocols, sterile injectable quality requirements, pharmacovigilance priorities, and the expanding role of digital and AI-enabled tools in healthcare operations.

Conclusion: Strategic Outlook for Local Anesthesia Drugs

Local anesthesia drugs remain foundational to modern procedural medicine, enabling safer, targeted analgesia across surgical, dental, obstetric, dermatologic, ophthalmic, and emergency care settings. The sector is evolving beyond basic anesthetic availability toward safety-centered formulations, longer-duration analgesia, outpatient workflow efficiency, and stronger supply reliability. Regional differences in healthcare infrastructure, regulation, procurement, and clinical practice create varied adoption patterns, while group-level dynamics across major economic and policy blocs highlight the importance of quality standards and access strategies. Artificial intelligence is adding value through research acceleration, pharmacovigilance, manufacturing quality, and supply chain intelligence, but its impact depends on validation, governance, and integration with clinical expertise. Organizations that combine evidence-based product development, reliable manufacturing, safety education, and region-specific access planning will be best positioned to meet the ongoing clinical need for effective local anesthesia drugs without compromising quality or patient safety.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Local Anesthesia Drugs Market, by Product Type
7.1. Introduction
7.2. Cream
7.3. Gel
7.4. Injection
7.5. Patch
7.6. Spray
8. Local Anesthesia Drugs Market, by Drug Class
8.1. Introduction
8.2. Amides
8.2.1. Bupivacaine
8.2.2. Lidocaine
8.2.3. Mepivacaine
8.2.4. Prilocaine
8.2.5. Ropivacaine
8.3. Esters
8.3.1. Benzocaine
8.3.2. Procaine
8.3.3. Tetracaine
9. Local Anesthesia Drugs Market, by Route Administration
9.1. Introduction
9.2. Infiltration
9.3. Nerve Block
9.4. Regional
9.5. Spinal
9.6. Topical
10. Local Anesthesia Drugs Market, by Packaging Type
10.1. Introduction
10.2. Ampoules
10.3. Vials
10.4. Pre Filled Syringes
10.5. Tubes
11. Local Anesthesia Drugs Market, by Application
11.1. Introduction
11.2. Surgical Procedures
11.2.1. Dental Surgery
11.2.2. Ophthalmic Surgery
11.3. Pain Management
11.3.1. Chronic Pain Management
11.3.2. Post Operative Pain Control
11.4. Diagnostic Procedures
11.4.1. Endoscopy
11.4.2. Biopsy Procedures
11.5. Cosmetic Procedures
12. Local Anesthesia Drugs Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgery Centers
12.3. Dental Clinics
12.4. Home Care
12.5. Hospitals
12.5.1. Private Hospitals
12.5.2. Public Hospitals
13. Local Anesthesia Drugs Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Local Anesthesia Drugs Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Local Anesthesia Drugs Market, by Group
15.1. NATO
15.2. G7
15.3. BRICS
15.4. European Union
15.5. ASEAN
15.6. GCC
16. Local Anesthesia Drugs Market, by Country
16.1. China
16.2. United States
16.3. Japan
16.4. India
16.5. Germany
16.6. United Kingdom
16.7. Australia
16.8. France
16.9. South Korea
16.10. Italy
16.11. Canada
16.12. Russia
16.13. Brazil
16.14. Mexico
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. AbbVie Inc.
18.2. Aspen Pharmacare Holdings Limited
18.3. AstraZeneca plc
18.4. B. Braun Melsungen AG
18.5. Baxter International Inc.
18.6. Dentsply Sirona Inc.
18.7. Fresenius SE & Co. KGaA
18.8. GlaxoSmithKline plc
18.9. Glenmark Pharmaceuticals Limited
18.10. Hikma Pharmaceuticals PLC
18.11. Luye Pharma Group
18.12. Merck & Co., Inc.
18.13. Novartis AG
18.14. Pacira BioSciences Inc.
18.15. Pfizer Inc.
18.16. Recordati S.p.A.
18.17. Septodont Holding
18.18. Sun Pharmaceutical Industries Ltd.
18.19. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2032 (%)
FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CREAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CREAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CREAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SPRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SPRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AMIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AMIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AMIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BUPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BUPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BUPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LIDOCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LIDOCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LIDOCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MEPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MEPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MEPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PRILOCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRILOCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRILOCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ROPIVACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ROPIVACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ROPIVACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ESTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ESTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ESTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BENZOCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BENZOCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BENZOCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROCAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PROCAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PROCAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TETRACAINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TETRACAINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TETRACAINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INFILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INFILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INFILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NERVE BLOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NERVE BLOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NERVE BLOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL REGIONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL REGIONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL REGIONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SPINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SPINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SPINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AMPOULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AMPOULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AMPOULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PRE FILLED SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PRE FILLED SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PRE FILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DENTAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DENTAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DENTAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OPHTHALMIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OPHTHALMIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OPHTHALMIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL POST OPERATIVE PAIN CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL POST OPERATIVE PAIN CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL POST OPERATIVE PAIN CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOPSY PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOPSY PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOPSY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COSMETIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COSMETIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COSMETIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 155. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 161. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 162. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 197. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 202. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 203. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 204. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 205. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 225. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 226. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 227. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 229. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 231. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 232. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 233. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 234. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 235. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 239. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 240. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 241. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 243. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 245. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 246. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 247. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 248. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 251. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 253. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 254. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 255. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 256. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 257. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 259. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 260. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 261. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 262. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 263. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 279. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 280. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 281. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 283. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 284. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 285. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 287. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 288. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 289. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 290. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 291. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 293. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 295. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 296. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 297. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 298. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 299. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 301. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 302. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 303. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 304. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 305. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 306. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 308. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 310. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 311. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 312. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 313. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 314. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 316. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 317. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 318. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 319. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 320. CHINA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 332. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 333. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 334. UNITED STATES LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 335. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 336. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 337. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 338. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 339. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 340. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 341. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 342. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 343. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 344. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 345. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 346. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 347. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 348. JAPAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 349. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 350. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 351. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 352. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2032 (USD MILLION)
TABLE 353. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2032 (USD MILLION)
TABLE 354. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 355. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 356. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 357. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 358. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 359. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
TABLE 360. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 361. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 362. INDIA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 363. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 364. GERMANY LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODU

Companies Mentioned

  • AbbVie Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dentsply Sirona Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Luye Pharma Group
  • Merck & Co., Inc.
  • Novartis AG
  • Pacira BioSciences Inc.
  • Pfizer Inc.
  • Recordati S.p.A.
  • Septodont Holding
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.71 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.2 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Local Anesthesia Drugs - Global Strategic Business Report - Product Image

Local Anesthesia Drugs - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Local Anesthesia Drugs Market Size, Share, Trends and Forecast by Drug Type, Mode of Administration, Distribution Channel, and Region, 2026-2034 - Product Image

Local Anesthesia Drugs Market Size, Share, Trends and Forecast by Drug Type, Mode of Administration, Distribution Channel, and Region, 2026-2034

  • Report
  • 143 Pages
  • Global
From
Local Anesthesia Drugs Market Report 2026 - Product Image

Local Anesthesia Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Local Anesthesia Drugs Market Report by Drug Type, Mode of Administration, Distribution Channel, Countries and Company Analysis 2026-2034 - Product Image

Local Anesthesia Drugs Market Report by Drug Type, Mode of Administration, Distribution Channel, Countries and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Anesthetic Drugs Market by Drug Type, Administration Route, Duration of Action, Application, End User, Distribution Channel - Global Forecast 2026-2032 - Product Image

Anesthetic Drugs Market by Drug Type, Administration Route, Duration of Action, Application, End User, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From

About the Market

Local Anesthesia is a type of anesthetic drug used to numb a specific area of the body. It is typically used for minor surgeries and procedures, such as dental work, and is administered through injection or topical application. Local anesthetics work by blocking nerve signals in the affected area, preventing pain signals from reaching the brain. They are generally considered safe and effective, with few side effects. The local anesthesia market is a subset of the larger anesthetic drugs market. It is composed of a variety of products, including injectable anesthetics, topical anesthetics, and anesthetic creams. These products are used in a variety of medical settings, including hospitals, clinics, and dental offices. Some of the major companies in the local anesthesia market include AstraZeneca, Baxter International, Hospira, Mylan, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.